Data as of Nov 21
| +0.56 / +0.84%|
The 20 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 65.50, with a high estimate of 80.00 and a low estimate of 59.00. The median estimate represents a -2.76% decrease from the last price of 67.36.
The current consensus among 22 polled investment analysts is to Hold stock in Eli Lilly and Co. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.